appropriate

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

1. 43/100

   Lecanemab in Singapore: Appropriate use recommendations for early Alzheimer's disease

   ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Annals of the Academy of Medicine, Singapore · 2026-11-04 · Treatments

   Lecanemab should only be prescribed for patients with MCI due to AD or mild AD dementia following careful clinical evaluation confirming AD pathology, with caution exercised in patients at increased ARIA risk (e.g. APOEε4 gene carriers).

   • Treatments
   • Clinical Trials
   • Brain Scans
2. 47/100

   Updated Italian intersocietal recommendations for the appropriate use of anti-amyloid monoclonal antibodies in Alzheimer's disease

   ✓ Peer-reviewed alzhub usefulness score 47 out of 100. The journal of prevention of Alzheimer's disease · 2026-10-15 · Treatments

   With the European authorisation of lecanemab and donanemab, Italy is entering the era of disease-modifying therapy for early symptomatic Alzheimer's disease.

   • Treatments
   • Brain Scans
3. 66/100

   Updated Appropriate Use Criteria for Amyloid and Tau PET: A Report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup

   ✓ Peer-reviewed alzhub usefulness score 66 out of 100. Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025-06-06 · Brain scans and imaging

   For amyloid PET, 7 scenarios were rated as appropriate, 2 as uncertain, and 8 as rarely appropriate.

   • Brain Scans
4. 72/100

   Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer's disease

   ✓ Peer-reviewed alzhub usefulness score 72 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association · 2018-10-10 · Tau biomarkers

   In anticipation of the emergence of more reliable CSF analysis platforms, the manuscript offers important guidance to health-care practitioners and suggestions for implementation and future research.

   • Biomarkers
   • Diagnosis
5. 36/100

   Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association

   ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2013-01-28 · Brain scans and imaging

   Positron emission tomography (PET) of brain amyloid β is a technology that is becoming more available, but its clinical utility in medical practice requires careful definition.

   • Brain Scans

All topic tags with their study counts